In a proof-of-principle study, researchers report that a certain liver immune cell called a macrophage contains only defective or inert HIV-1 copies, and aren't likely to restart infection on their own in HIV-1-infected people on long-term antiretroviral therapy (ART).
from Latest Science News -- ScienceDaily https://ift.tt/2P3GmBs
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment